Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee McDaniel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Research Square|January 7, 2025
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responsesAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Scientific Reports|March 24, 2026
Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patientsAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Cancer Research|June 24, 2015
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility LocusMike R Russell, Annalise Penikis, Derek A Oldridge, et al.
Nature Communications|September 20, 2017
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma riskXiao Chang, Yan Zhao, Cuiping Hou, et al.
Nature Communications|July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinomaJacob E Till, Lee McDaniel, Changgee Chang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Research Square|January 7, 2025
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responsesAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Scientific Reports|March 24, 2026
Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patientsAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Cancer Research|June 24, 2015
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility LocusMike R Russell, Annalise Penikis, Derek A Oldridge, et al.
Nature Communications|September 20, 2017
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma riskXiao Chang, Yan Zhao, Cuiping Hou, et al.
Nature Communications|July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinomaJacob E Till, Lee McDaniel, Changgee Chang, et al.
Pageof 2